Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Weber

Showing results (131-140 of 341) with videos related to

Pageof 35
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|October 2, 2010
Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS studyGeorge L Bakris, Malini Iyengar, Mary Ann Lukas, et al.
Swiss Medical Weekly|February 21, 2025
The key role of base rates: systematic review and meta-analysis of the predictive value of four risk assessment instrumentsMichael A Weber, Nina Schnyder, Madeleine A Kirschstein, et al.
CNS Drugs|January 30, 2020
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development ProgramTeodora Doherty, Ewa Wajs, Rama Melkote, et al.
Annals of Vascular Surgery|October 5, 2010
Endovascular repair of an abdominal aortic aneurysm in a patient with stenosis of bilateral common iliac artery stentsLeo J Daab, Gilbert Aidinian, Michael A Weber, et al.
Blood Pressure|December 2, 2015
Effects of dapagliflozin on blood pressure in hypertensive diabetic patients on renin-angiotensin system blockadeMichael A Weber, Traci A Mansfield, Federica Alessi, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2003
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blockerMichael A Weber, George L Bakris, Joel M Neutel, et al.
Lancet (London, England)|April 22, 2023
Fluid retention and heart failure in the PRECISION trial - Authors' replyMarkus P Schlaich, Marc Bellet, Michael A Weber, et al.
Journal of Hypertension|September 26, 2024
Impact of expected blood pressure reduction on patient preferences for pharmaceutical and renal denervation treatmentAtul Pathak, Michael A Weber, Christine Poulos, et al.
American Journal of Hypertension|June 12, 2003
Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trialThomas D Giles, George L Bakris, David H G Smith, et al.
The Lancet. Diabetes & Endocrinology|December 2, 2015
Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 studyMichael A Weber, Traci A Mansfield, Valerie A Cain, et al.
Pageof 35

Showing results (131-140 of 341) with videos related to

Sort By:
Pageof 35
Journal of Clinical Hypertension (Greenwich, Conn.)|October 2, 2010
Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS studyGeorge L Bakris, Malini Iyengar, Mary Ann Lukas, et al.
Swiss Medical Weekly|February 21, 2025
The key role of base rates: systematic review and meta-analysis of the predictive value of four risk assessment instrumentsMichael A Weber, Nina Schnyder, Madeleine A Kirschstein, et al.
CNS Drugs|January 30, 2020
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development ProgramTeodora Doherty, Ewa Wajs, Rama Melkote, et al.
Annals of Vascular Surgery|October 5, 2010
Endovascular repair of an abdominal aortic aneurysm in a patient with stenosis of bilateral common iliac artery stentsLeo J Daab, Gilbert Aidinian, Michael A Weber, et al.
Blood Pressure|December 2, 2015
Effects of dapagliflozin on blood pressure in hypertensive diabetic patients on renin-angiotensin system blockadeMichael A Weber, Traci A Mansfield, Federica Alessi, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2003
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blockerMichael A Weber, George L Bakris, Joel M Neutel, et al.
Lancet (London, England)|April 22, 2023
Fluid retention and heart failure in the PRECISION trial - Authors' replyMarkus P Schlaich, Marc Bellet, Michael A Weber, et al.
Journal of Hypertension|September 26, 2024
Impact of expected blood pressure reduction on patient preferences for pharmaceutical and renal denervation treatmentAtul Pathak, Michael A Weber, Christine Poulos, et al.
American Journal of Hypertension|June 12, 2003
Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trialThomas D Giles, George L Bakris, David H G Smith, et al.
The Lancet. Diabetes & Endocrinology|December 2, 2015
Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 studyMichael A Weber, Traci A Mansfield, Valerie A Cain, et al.
Pageof 35